Manufacturing defect leads to temporary halt of rabies vaccine production

04/29/2010 | SmallAnimalChannel.com

Merial recently announced that it has temporarily stopped releasing IMRAB rabies vaccines, after discovering a defect in a small number of vials. The problem doesn't affect doses on the market, a spokeswoman said. "Merial is working cooperatively with the USDA to remedy the issues and return to full supply as soon as possible," the Duluth, Ga., company said.

View Full Article in:

SmallAnimalChannel.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA